Skip to content

Use of Compressed Sensing in Breast MRI

Use of Compressed Sensing in Breast MRI

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02826369
Acronym
COMPRIM
Enrollment
13
Registered
2016-07-11
Start date
2016-03-29
Completion date
2016-04-12
Last updated
2018-08-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

Algorithms, Image Processing, Computer-Assisted/methods*, Magnetic Resonance Imaging/methods*, Data Compression, Breast Neoplasms

Brief summary

Breast MRI is increasingly important in breast screening imaging. It is currently based on dynamic sequences after contrast injection whose temporal resolution must be less than 90 seconds with dynamic acquisitions at different times. These curves profiles are designed to differentiate benign from malignant lesions. Recently, Mann et al, (2014) showed that increasing the temporal resolution of dynamic acquisitions; lesion enhancement curves over time were more accurate than the curves usually performed. It seems necessary to work on sequences having better temporal resolution without compromising however spatial resolution.

Interventions

OTHER3.0 Tesla in Magnetic Resonance Imaging

Eligible patient will have a standard MRI. The images taken before 4min30 and after 6min after to the injection of gadolimium contrast medium will be carried out with the standard image acquisition. The images taken between 4min30 and 6min after the injection of gadolimium contrast medium will be carried out with the compressed sensing image acquisition.

Sponsors

Institut de Cancérologie de Lorraine
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
No minimum to 18 Years
Healthy volunteers
No

Inclusion criteria

* Patient to benefit a MRI in the assessment for a breast carcinoma * Age \>18 years old * Assessment on 3.0 Tesla in Magnetic Resonance Imaging * ECOG performance status ≤ 3 * Ability to provide an informed written consent form

Exclusion criteria

* Age \< 18 years old * Claustrophobia * Contraindication to the injection of gadolinium contrast medium * Contraindication to MRI * Persons deprived of liberty or under supervision

Design outcomes

Primary

MeasureTime frameDescription
Agreement between compressed sensing and standard image acquisition1 dayAgreement between compressed sensing and standard image acquisition is defined by percentage of lesions detected by both modes of acquisitions

Secondary

MeasureTime frameDescription
Analysis of dammage contours1 dayAnalysis of lesions contours will be performed according to Bi-RADS classification
Image quality in compressed sensing acquisition1 dayThe image quality will be evaluated using a quality scale

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026